SCHEDULE 13G

Statement of Beneficial Ownership

Transcode Therapeutics, Inc. Filed 2025-02-14 Acc 0000950170-25-021455

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-02-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-01-03 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)